Sangamo Therapeutics $SGMO overblown selloff, could bounce high
Look for sustained rally upwards from 50 day average, powerfull buy signal could be triggered and could move the stock closer to its consensus price target of $13.50
https://www.smarteranalyst.com/new-blurbs/sangamo-biosciences-sgmo-gets-a-buy-rating-from-cowen-co/
SGMO
https://investor.sangamo.com/news-releases/news-release-details/sangamo-announces-early-completion-transfer-pfizer-sb-525
https://investor.sangamo.com/news-releases/news-release-details/sangamo-highlights-advancements-genomic-medicine-pipeline-and
https://www.smarteranalyst.com/new-blurbs/sangamo-biosciences-sgmo-gets-a-buy-rating-from-cowen-co/
SGMO https://investor.sangamo.com/news-releases/news-release-details/sangamo-announces-early-completion-transfer-pfizer-sb-525
https://investor.sangamo.com/news-releases/news-release-details/sangamo-highlights-advancements-genomic-medicine-pipeline-and
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.